SCHEMBL7122859

SCHEMBL7122859

O=C(Nc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1)c1ccncc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.86
SMN1; SMN2 Q16637 4/20 0.86
PPARG P37231 3/20 0.86
CYP3A4 P08684 2/20 0.86
ALOX15 P16050 1/20 0.86
PPARA Q07869 1/20 0.86
KMT2A Q03164 6/20 0.69
MEN1 O00255 4/20 0.69
RORC P51449 4/20 0.69
MAPT P10636 3/20 0.69
LMNA P02545 2/20 0.69
TP53 P04637 1/20 0.69
CYP1A2 P05177 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
PKM P14618 1/20 0.69
TSHR P16473 1/20 0.69
NFKB1 P19838 1/20 0.69
CYP2C19 P33261 1/20 0.69
THPO P40225 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127507 0.96 PPARG (0.80) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL2128178 0.92 SMN1; SMN2 (1.00) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL29369085 0.92 SMN1; SMN2 (1.00) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
Hydrochloric Acid SCHEMBL7125284 0.91 SMN1; SMN2 (0.97) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL27886556 0.90 SMN1; SMN2 (0.90) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL7127082 0.88 SMN1; SMN2 (0.86) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL7129256 0.88 RORC (0.85) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL7130609 0.87 RORC (0.84) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL7128348 0.87 SMN1; SMN2 (0.72) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15
SCHEMBL7123399 0.86 SMN1; SMN2 (0.71) MAPK1SMN1; SMN2PPARGCYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPK1 231/4885SMN1; SMN2 3743/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.